SG10201606581RA - Pyrazolopyrimidinyl inhibitors of ubiquitin-activating enzyme - Google Patents

Pyrazolopyrimidinyl inhibitors of ubiquitin-activating enzyme

Info

Publication number
SG10201606581RA
SG10201606581RA SG10201606581RA SG10201606581RA SG10201606581RA SG 10201606581R A SG10201606581R A SG 10201606581RA SG 10201606581R A SG10201606581R A SG 10201606581RA SG 10201606581R A SG10201606581R A SG 10201606581RA SG 10201606581R A SG10201606581R A SG 10201606581RA
Authority
SG
Singapore
Prior art keywords
ubiquitin
activating enzyme
pyrazolopyrimidinyl
inhibitors
pyrazolopyrimidinyl inhibitors
Prior art date
Application number
SG10201606581RA
Other languages
English (en)
Inventor
Roushan Afroze
Indu T Bharathan
Jeffrey P Ciavarri
Paul E Fleming
Jeffrey L Gaulin
Mario Girard
Steven P Langston
Francois R Soucy
Tzu-Tshin Wong
Yingchun Ye
Original Assignee
Millennium Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Millennium Pharm Inc filed Critical Millennium Pharm Inc
Publication of SG10201606581RA publication Critical patent/SG10201606581RA/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
SG10201606581RA 2012-02-17 2013-02-14 Pyrazolopyrimidinyl inhibitors of ubiquitin-activating enzyme SG10201606581RA (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201261600070P 2012-02-17 2012-02-17

Publications (1)

Publication Number Publication Date
SG10201606581RA true SG10201606581RA (en) 2016-09-29

Family

ID=48982730

Family Applications (2)

Application Number Title Priority Date Filing Date
SG10201606581RA SG10201606581RA (en) 2012-02-17 2013-02-14 Pyrazolopyrimidinyl inhibitors of ubiquitin-activating enzyme
SG11201404757WA SG11201404757WA (en) 2012-02-17 2013-02-14 Pyrazolopyrimidinyl inhibitors of ubiquitin-activating enzyme

Family Applications After (1)

Application Number Title Priority Date Filing Date
SG11201404757WA SG11201404757WA (en) 2012-02-17 2013-02-14 Pyrazolopyrimidinyl inhibitors of ubiquitin-activating enzyme

Country Status (30)

Country Link
US (4) US9290500B2 (es)
EP (3) EP3536692B1 (es)
JP (1) JP6122877B2 (es)
KR (1) KR20140123104A (es)
CN (1) CN104136399B (es)
AR (1) AR092797A1 (es)
BR (1) BR112014020365B1 (es)
CA (1) CA2864672C (es)
CL (1) CL2014002181A1 (es)
CO (1) CO7071135A2 (es)
CR (1) CR20140380A (es)
DO (1) DOP2014000187A (es)
EA (1) EA035020B1 (es)
EC (1) ECSP14019113A (es)
ES (1) ES2739150T3 (es)
GE (1) GEP201706687B (es)
HK (1) HK1201817A1 (es)
IL (1) IL234016A0 (es)
MA (1) MA35932B1 (es)
MX (1) MX352963B (es)
NZ (1) NZ628969A (es)
PE (1) PE20142244A1 (es)
PH (1) PH12014501832A1 (es)
SG (2) SG10201606581RA (es)
TN (1) TN2014000351A1 (es)
TW (1) TWI593688B (es)
UA (1) UA116534C2 (es)
UY (1) UY34629A (es)
WO (1) WO2013123169A1 (es)
ZA (1) ZA201406103B (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8008307B2 (en) 2006-08-08 2011-08-30 Millennium Pharmaceuticals, Inc. Heteroaryl compounds useful as inhibitors of E1 activating enzymes
CA2864672C (en) 2012-02-17 2018-01-09 Millennium Pharmaceuticals, Inc. Pyrazolopyrimidinyl inhibitors of ubiquitin-activating enzyme
JP2015524442A (ja) 2012-08-03 2015-08-24 ミレニアム ファーマシューティカルズ, インコーポレイテッドMillennium Pharmaceuticals, Inc. Uba6のインドール置換ピロロピリミジニル阻害剤
CA2916468C (en) 2013-07-02 2019-07-23 Millennium Pharmaceuticals, Inc. Heteroaryl compounds useful as inhibitors of sumo activating enzyme
CR20170021A (es) * 2014-07-01 2017-04-04 Millennium Pharm Inc Compuestos de heteroarilo útiles como inhibidores de enzima activadora de sumo
JP6697453B2 (ja) 2014-10-29 2020-05-20 ミレニアム ファーマシューティカルズ, インコーポレイテッドMillennium Pharmaceuticals, Inc. ユビキチン活性化酵素阻害物質及び放射線の投与
WO2016069392A1 (en) 2014-10-29 2016-05-06 Millennium Pharmaceuticals, Inc. Administration of ubiquitin-activating enzyme inhibitor and chemotherapeutic agents
JP7385658B2 (ja) 2018-10-30 2023-11-22 クロノス バイオ インコーポレイテッド Cdk9活性を調節するための化合物、組成物、および方法
WO2023021498A1 (en) * 2021-08-16 2023-02-23 Moya Bio Ltd. Fused azole and furan based nucleoside analogs and uses thereof

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005524662A (ja) 2002-02-28 2005-08-18 ビオタ インコーポレーティッド ヌクレオシド5’−一リン酸模倣物およびこれらのプロドラッグ
AR041134A1 (es) 2002-09-04 2005-05-04 Schering Corp Pirazolopirimidinas como inhibidores de la quinasa dependiente de ciclina
AR041133A1 (es) 2002-09-04 2005-05-04 Pharmacopeia Drug Discovery Pirazolopirimidinas como inhibidores de la quinasa dependientes de la ciclina
US7563798B2 (en) 2002-09-04 2009-07-21 Schering Corporation Substituted pyrazolo[1,5-a]pyrimidines as protein kinase inhibitors
US7196092B2 (en) 2002-09-04 2007-03-27 Schering Corporation N-heteroaryl pyrazolopyrimidines as cyclin dependent kinase inhibitors
EP1608652A1 (en) 2003-03-31 2005-12-28 Vernalis (Cambridge) Limited Pyrazolopyrimidine compounds and their use in medicine
JP2005008581A (ja) 2003-06-20 2005-01-13 Kissei Pharmaceut Co Ltd 新規なピラゾロ[1,5−a]ピリミジン誘導体、それを含有する医薬組成物およびそれらの用途
EP1680431A1 (en) 2003-10-17 2006-07-19 Rigel Pharmaceuticals, Inc. Benzothiazole and thiazole'5,5-b!pyridine compositions and their use as ubiquitin ligase inhibitors
WO2006002284A1 (en) 2004-06-22 2006-01-05 Rigel Pharmaceuticals, Inc. Ubiquitin ligase inhibitors
ME02012B (me) 2005-02-04 2013-02-28 Millennium Pharm Inc INHIBITORI El AKTIVIRAJUĆIH ENZIMA
CA2624826A1 (en) 2005-10-06 2007-04-19 Schering Corporation Pyrazolopyrimidines as protein kinase inhibitors
SG169369A1 (en) * 2006-02-02 2011-03-30 Millennium Pharm Inc Inhibitors of e1 activating enzymes
JP4953472B2 (ja) * 2006-02-28 2012-06-13 ラム・リサーチ・アクチエンゲゼルシヤフト ディスク状物品を液体処理する装置及び方法
US8008307B2 (en) 2006-08-08 2011-08-30 Millennium Pharmaceuticals, Inc. Heteroaryl compounds useful as inhibitors of E1 activating enzymes
KR101538103B1 (ko) * 2006-08-08 2015-07-22 밀레니엄 파머슈티컬스 인코퍼레이티드 E1 활성화 효소의 억제제로서 유용한 헤테로아릴 화합물
CA2934114A1 (en) 2007-06-12 2008-12-18 Achaogen, Inc. Antibacterial agents
CN106243111B (zh) * 2007-08-02 2019-07-23 米伦纽姆医药公司 合成e1活化酶抑制剂的方法
WO2009082691A1 (en) 2007-12-21 2009-07-02 Board Of Regents, University Of Texas System Dihydroorotate dehydrogenase inhibitors with selective anti-malarial activity
WO2010086040A1 (en) 2009-01-29 2010-08-05 Biomarin Iga, Ltd. Pyrazolo-pyrimidines for treatment of duchenne muscular dystrophy
WO2010088518A2 (en) 2009-01-31 2010-08-05 Kalypsys, Inc. Heterocyclic modulators of gpr119 for treatment of disease
EP3091020B1 (en) 2009-05-14 2020-12-30 Millennium Pharmaceuticals, Inc. Hydrochloride salt of ((1s,2s,4r)-4-{4-[(1s)-2,3-dihydro-1h-inden-1-ylamino]-7h-pyrrolo[2,3-d]pyrimidin-7-yl}-2-hydroxycyclopentyl)methyl sulfamate
CA2791738C (en) 2010-03-01 2020-06-09 Gtx, Inc. Aryl imidazolyl compounds for the treatment of cancer
US20120077814A1 (en) 2010-09-10 2012-03-29 Zhong Wang Sulfonamide, sulfamate, and sulfamothioate derivatives
CN103889988B (zh) 2011-08-24 2018-05-04 米伦纽姆医药公司 Nedd8-活化酶的抑制剂
CA2864672C (en) 2012-02-17 2018-01-09 Millennium Pharmaceuticals, Inc. Pyrazolopyrimidinyl inhibitors of ubiquitin-activating enzyme
JP2015524442A (ja) 2012-08-03 2015-08-24 ミレニアム ファーマシューティカルズ, インコーポレイテッドMillennium Pharmaceuticals, Inc. Uba6のインドール置換ピロロピリミジニル阻害剤
CA2916468C (en) 2013-07-02 2019-07-23 Millennium Pharmaceuticals, Inc. Heteroaryl compounds useful as inhibitors of sumo activating enzyme
CR20170021A (es) 2014-07-01 2017-04-04 Millennium Pharm Inc Compuestos de heteroarilo útiles como inhibidores de enzima activadora de sumo

Also Published As

Publication number Publication date
US20140088096A9 (en) 2014-03-27
EP2814791A1 (en) 2014-12-24
MX2014009944A (es) 2014-11-10
HK1201817A1 (en) 2015-09-11
PH12014501832A1 (en) 2014-11-17
UA116534C2 (uk) 2018-04-10
AR092797A1 (es) 2015-05-06
CL2014002181A1 (es) 2014-12-12
ZA201406103B (en) 2017-11-29
EA035020B1 (ru) 2020-04-17
JP6122877B2 (ja) 2017-04-26
BR112014020365A2 (pt) 2020-12-22
SG11201404757WA (en) 2014-09-26
JP2015508775A (ja) 2015-03-23
US9796725B2 (en) 2017-10-24
CR20140380A (es) 2014-10-28
CA2864672C (en) 2018-01-09
EP3536692A1 (en) 2019-09-11
US20170369499A1 (en) 2017-12-28
US9290500B2 (en) 2016-03-22
NZ628969A (en) 2017-03-31
US10202389B2 (en) 2019-02-12
ECSP14019113A (es) 2015-09-30
TW201345909A (zh) 2013-11-16
US9663525B2 (en) 2017-05-30
CO7071135A2 (es) 2014-09-30
CN104136399A (zh) 2014-11-05
US20170217968A1 (en) 2017-08-03
ES2739150T3 (es) 2020-01-29
IL234016A0 (en) 2014-09-30
CA2864672A1 (en) 2013-08-22
TN2014000351A1 (en) 2015-12-21
MX352963B (es) 2017-12-15
DOP2014000187A (es) 2014-10-15
GEP201706687B (en) 2017-06-26
KR20140123104A (ko) 2014-10-21
EA201400831A1 (ru) 2014-12-30
PE20142244A1 (es) 2015-01-07
BR112014020365B1 (pt) 2023-02-23
MA35932B1 (fr) 2014-12-01
EP3173413A1 (en) 2017-05-31
TWI593688B (zh) 2017-08-01
UY34629A (es) 2013-09-02
US20130217682A1 (en) 2013-08-22
EP2814791A4 (en) 2015-08-19
WO2013123169A1 (en) 2013-08-22
EP3173413B1 (en) 2019-05-01
EP3536692B1 (en) 2021-04-07
CN104136399B (zh) 2018-08-07
US20160244455A1 (en) 2016-08-25

Similar Documents

Publication Publication Date Title
HK1207078A1 (en) Inhibition of enzymes
HK1201519A1 (en) Inhibitors of phosphodiesterase type 10a 10a
HK1210140A1 (en) Fused pyrimidines as inhibitors of p97 complex p97
HK1206736A1 (en) Seca inhibitors and methods of making and using thereof seca
EP2903613A4 (en) INHIBITORS OF IRAQ4 ACTIVITY
EP2903617A4 (en) INHIBITORS OF IRAQ4 ACTIVITY
AP4029A (en) Inhibitors of beta-secretase
LT2855480T (lt) Pteridinai kaip fgfr inhibitoriai
HK1201817A1 (en) Pyrazolopyrimidinyl inhibitors of ubiquitin-activating enzyme
HK1199252A1 (en) Inhibitors of nedd8-activating enzyme nedd8-
HK1211024A1 (en) Inhibitors of syk syk
IL236963A0 (en) beta-secretase inhibitors
PL2931710T3 (pl) Pirydazynony jako inhibitory enzymu DAAO
HK1201066A1 (en) Pyranopyridone inhibitors of tankyrase
PL2888228T3 (pl) Inhibitory oddziaływania CD40-TRAF6
EP2714667A4 (en) AMINOOXAZOLE INHIBITORS OF KINASES DEPENDENT OF CYCLIN
AP2014007697A0 (en) Quinoline derivatives as PDE1OA enzyme inhibitors
GB201312311D0 (en) Uses of enzyme inhibitors
GB201223308D0 (en) Enzyme inhibitors
AU2012905067A0 (en) IMPROVED INHIBITORS OF Grb7